Davis's Drug Guide
osimertinib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
oh-si-mer-ti-nib
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Tagrisso
Ther. Class.
Pharm. Class.
epidermal growth factor receptor (EGFR) inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Osimertinib." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110401/all/osimertinib.
Vallerand AHA, Sanoski CAC, Quiring CC. Osimertinib. Davis's Drug Guide. F.A. Davis Company; 2024. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110401/all/osimertinib. Accessed November 15, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Osimertinib. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110401/all/osimertinib
Vallerand AHA, Sanoski CAC, Quiring CC. Osimertinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 November 15]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110401/all/osimertinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - osimertinib
ID - 110401
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110401/all/osimertinib
PB - F.A. Davis Company
ET - 19
DB - Emergency Central
DP - Unbound Medicine
ER -
